INSULIN RESISTANCE IN CHRONIC HEPATITIS C VIRUS PATIENTS RECEIVING DIRECT ACTING ANTIVIRAL DRUGS

Effect of Direct-Acting Antivirals on Lipid and Glucose Metabolism in Chronic HCV Patients

Insulin resistance and portal heamodynamics changes before and after treatment by new direct antivirals drugs in chronic HCV

Impact of Hepatitis C virus Infection and direct-acting Oral Antiviral Drugs on glycaemic state in Type 2 Diabetic Patients

Impact of sustained virologic response on glycemic control among diabetic patients with hepatitis C virus-related liver disease

Effect of HCV Eradication on Glycemic Control of Type 2 Diabetes Mellitus

OUTCOME OF ERADICATION OF CHRONIC HEPATITIS C VIRUS INFECTION WITH DIRECT ACTING ANTIVIRAL AGENTS ON BLOOD SUGAR CONTROL AND INSULIN RESISTANCE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

Effect of Treatment With Direct Acting Antivirals on Glucose and Lipid Metabolism in Egyptian Patients With Chronic Hepatitis C

Direct Acting Antivirals Impact on Biochemical, Immunological and Hematological Responses in HCV Infected Patients

IMPACT OF DIABETIC CONTROL ON ACHIEVING SUSTAINED VIROLOGIC RESPONSE IN CHRONIC HCV PATIENTS RECEIVING DIRECT-ACTING ANTIVIRALS